Literature DB >> 18187133

Inducible nitric oxide synthase and estradiol exhibit complementary neuroprotective roles after ischemic brain injury.

Candice M Brown1, Christopher D Dela Cruz, Enhua Yang, Phyllis M Wise.   

Abstract

Estradiol-17beta exerts profound neuroprotective actions following cerebral ischemia through multiple molecular mechanisms. To examine the putative anti-inflammatory mechanisms employed by estradiol during stroke, we explored the interactions between estradiol and inducible nitric oxide synthase (iNOS) in both wildtype and iNOS knockout (iNOSKO) female mice following permanent middle cerebral artery occlusion (MCAO). Female mice were ovariectomized and treated with estradiol. One week later, they were subjected to MCAO, and then killed 24 h later. Analysis of total, cortical and striatal infarct volumes confirmed that estradiol is neuroprotective in wildtype mice. Infarct volumes were also significantly smaller in female iNOSKO female mice, but estradiol did not further decrease injury. We found that one mechanism by which estradiol may act is by decreasing nitric oxide synthase 2 gene expression in the cortex and in the striatum of wildtype mice. These results show that the pro-inflammatory actions of iNOS exacerbate stroke-induced injury within the cortex and striatum, and that iNOS deletion is neuroprotective in ovariectomized and estrogen-replaced female mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18187133      PMCID: PMC2515226          DOI: 10.1016/j.expneurol.2007.11.021

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  33 in total

Review 1.  Regulation of the expression of inducible nitric oxide synthase.

Authors:  Hartmut Kleinert; Petra M Schwarz; Ulrich Förstermann
Journal:  Biol Chem       Date:  2003 Oct-Nov       Impact factor: 3.915

Review 2.  Inflammatory mechanisms after ischemia and stroke.

Authors:  Gary H Danton; W Dalton Dietrich
Journal:  J Neuropathol Exp Neurol       Date:  2003-02       Impact factor: 3.685

Review 3.  Mechanisms of neuroprotection by estrogen.

Authors:  Shotaro Suzuki; Candice M Brown; Phyllis M Wise
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

5.  Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group.

Authors:  Cheryl D Bushnell; Patricia Hurn; Carol Colton; Virginia M Miller; Gregory del Zoppo; Mitchell S V Elkind; Barney Stern; David Herrington; Gwendolyn Ford-Lynch; Philip Gorelick; Andra James; Candice M Brown; Emily Choi; Paul Bray; L Kristin Newby; Larry B Goldstein; James Simpkins
Journal:  Stroke       Date:  2006-07-20       Impact factor: 7.914

Review 6.  Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies.

Authors:  Judith L Turgeon; Molly C Carr; Pauline M Maki; Michael E Mendelsohn; Phyllis M Wise
Journal:  Endocr Rev       Date:  2006-06-09       Impact factor: 19.871

7.  Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions.

Authors:  Shotaro Suzuki; Candice M Brown; Christopher D Dela Cruz; Enhua Yang; David A Bridwell; Phyllis M Wise
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

8.  Effects of aminoguanidine on cerebral ischemia in mice: comparison between mice with and without inducible nitric oxide synthase gene.

Authors:  Koreaki Sugimoto; Costantino Iadecola
Journal:  Neurosci Lett       Date:  2002-10-04       Impact factor: 3.046

9.  Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death.

Authors:  Dena B Dubal; Shane W Rau; Paul J Shughrue; Hong Zhu; Jin Yu; Adrienne B Cashion; Shotaro Suzuki; Lynnette M Gerhold; Martina B Bottner; Sam B Dubal; Istvan Merchanthaler; Mark S Kindy; Phyllis M Wise
Journal:  Endocrinology       Date:  2006-03-09       Impact factor: 4.736

10.  Estradiol differentially regulates c-Fos after focal cerebral ischemia.

Authors:  Shane W Rau; Dena B Dubal; Martina Böttner; Phyllis M Wise
Journal:  J Neurosci       Date:  2003-11-19       Impact factor: 6.167

View more
  6 in total

Review 1.  Neuroprotection of sex steroids.

Authors:  M Liu; M H Kelley; P S Herson; P D Hurn
Journal:  Minerva Endocrinol       Date:  2010-06       Impact factor: 2.184

Review 2.  Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Authors:  E B Engler-Chiurazzi; C M Brown; J M Povroznik; J W Simpkins
Journal:  Prog Neurobiol       Date:  2016-02-15       Impact factor: 11.685

3.  Microparticles generated by decompression stress cause central nervous system injury manifested as neurohypophysial terminal action potential broadening.

Authors:  Ming Yang; Paul Kosterin; Brian M Salzberg; Tatyana N Milovanova; Veena M Bhopale; Stephen R Thom
Journal:  J Appl Physiol (1985)       Date:  2013-09-19

Review 4.  Mechanisms of estrogens' dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia.

Authors:  Jakob O Strom; Annette Theodorsson; Elvar Theodorsson
Journal:  Int J Mol Sci       Date:  2011-02-25       Impact factor: 5.923

Review 5.  Neuroprotective effects of estrogens following ischemic stroke.

Authors:  Shotaro Suzuki; Candice M Brown; Phyllis M Wise
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606

Review 6.  Estradiol is a potent protective, restorative, and trophic factor after brain injury.

Authors:  Candice M Brown; Shotaro Suzuki; Karen A B Jelks; Phyllis M Wise
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.